Clinical Trial Update: Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 platform study evaluating rechallenge with antibody-drug conjugates in ADC-treated metastatic breast cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Advanced Breast Cancer, Metastatic Breast Cancer | Phase 2 | Status: RECRUITING